---
document_datetime: 2023-09-21 18:28:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/osigraft-epar-all-authorised-presentations_en.pdf
document_name: osigraft-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3495769
conversion_datetime: 2025-12-19 22:33:46.149793
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
EU Number

EU/1/01/179/001

Invented name

Osigraft

Strength

3.3 mg

Pharmaceutical Form

Powder for suspension for implantation

Route of

Administration

Intraosseous use

Packaging

Vial (glass)

Content

1 g

Medicinal product no longer authorised

Package size

1 vial